A200230 Stock Overview
Primarily engages in the development, production, and sale of RF coaxial connectors worldwide.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
TELCON RF PHARMACEUTICAL. Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩789.00 |
52 Week High | ₩1,238.00 |
52 Week Low | ₩625.00 |
Beta | 0.075 |
1 Month Change | -1.25% |
3 Month Change | 13.85% |
1 Year Change | -32.51% |
3 Year Change | -83.09% |
5 Year Change | -87.65% |
Change since IPO | -32.85% |
Recent News & Updates
Investors Shouldn't Be Too Comfortable With TELCON RF PHARMACEUTICAL's (KOSDAQ:200230) Earnings
Mar 26TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230) Investors Are Less Pessimistic Than Expected
Mar 13Recent updates
Investors Shouldn't Be Too Comfortable With TELCON RF PHARMACEUTICAL's (KOSDAQ:200230) Earnings
Mar 26TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230) Investors Are Less Pessimistic Than Expected
Mar 13Is TELCON RF PHARMACEUTICAL (KOSDAQ:200230) Using Too Much Debt?
Apr 05Did Business Growth Power TELCON RF PHARMACEUTICAL's (KOSDAQ:200230) Share Price Gain of 218%?
Feb 03Shareholder Returns
A200230 | KR Electronic | KR Market | |
---|---|---|---|
7D | 8.1% | -1.5% | -1.7% |
1Y | -32.5% | -24.1% | 0.6% |
Return vs Industry: A200230 underperformed the KR Electronic industry which returned -24.1% over the past year.
Return vs Market: A200230 underperformed the KR Market which returned 0.6% over the past year.
Price Volatility
A200230 volatility | |
---|---|
A200230 Average Weekly Movement | 6.4% |
Electronic Industry Average Movement | 5.8% |
Market Average Movement | 5.1% |
10% most volatile stocks in KR Market | 11.3% |
10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A200230 has not had significant price volatility in the past 3 months.
Volatility Over Time: A200230's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 113 | Jin-Hun Lim | www.telcon.co.kr |
TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals.
TELCON RF PHARMACEUTICAL. Inc. Fundamentals Summary
A200230 fundamental statistics | |
---|---|
Market cap | ₩91.52b |
Earnings (TTM) | -₩40.74b |
Revenue (TTM) | ₩37.19b |
2.5x
P/S Ratio-2.2x
P/E RatioIs A200230 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A200230 income statement (TTM) | |
---|---|
Revenue | ₩37.19b |
Cost of Revenue | ₩27.58b |
Gross Profit | ₩9.60b |
Other Expenses | ₩50.34b |
Earnings | -₩40.74b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -351.21 |
Gross Margin | 25.83% |
Net Profit Margin | -109.56% |
Debt/Equity Ratio | 27.3% |
How did A200230 perform over the long term?
See historical performance and comparison